Sai Life Sciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 493.04 | 576.83 | 438.05 |
| Operating Expense | 370.04 | 413.11 | 317.41 |
| Net Profit | 58.37 | 89.94 | 51.06 |
| Net Profit Margin | 11.84 | 15.59 | 11.66 |
| Earning Per Share | 2.80 | 4.32 | 2.74 |
| EBIDTA | 117.26 | 150.73 | 113.69 |
| Effective Tax Rate | 11.27 | 10.71 | 8.21 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 493.04 |
| Operating Expense | 370.04 |
| Net Profit | 58.37 |
| Net Profit Margin | 11.84 |
| Earning Per Share | 2.80 |
| EBIDTA | 117.26 |
| Effective Tax Rate | 11.27 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 1,642.05 | 1,418.68 | 1,157.40 |
| Operating Expenses Annual | 1,251.60 | 1,132.07 | 994.26 |
| Operating Profit Annual | 427.78 | 315.94 | 191.10 |
| Interest Annual | 70.03 | 79.72 | 70.64 |
| Depreciation | 116.77 | 98.80 | 83.49 |
| Net Profit Annual | 173.46 | 95.23 | 24.24 |
| Tax Annual | 58.25 | 33.77 | 8.45 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 1,642.05 |
| Operating Expenses Annual | 1,251.60 |
| Operating Profit Annual | 427.78 |
| Interest Annual | 70.03 |
| Depreciation | 116.77 |
| Net Profit Annual | 173.46 |
| Tax Annual | 58.25 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 5.17 | 29.21 | 109.01 |
| Cash Flow from Operations | 330.35 | 250.64 | 221.47 |
| Cash Flow from Investing | -564.71 | -190.05 | -111.23 |
| Cash Flow from Financing | 314.31 | -84.63 | -190.04 |
| Cash Flow at the End | 85.12 | 5.17 | 29.21 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 5.17 |
| Cash Flow from Operations | 330.35 |
| Cash Flow from Investing | -564.71 |
| Cash Flow from Financing | 314.31 |
| Cash Flow at the End | 85.12 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 26.17 | 22.37 | 16.83 |
| PBIT Margin (%) | 18.49 | 14.81 | 9.25 |
| PBT Margin (%) | 18.23 | 14.63 | 9.13 |
| Net PROFIT Margin (%) | 10.56 | 6.71 | 2.09 |
| Return On Networth / Equity (%) | 10.92 | 9.90 | 2.69 |
| Return On Networth /Employed (%) | 13.87 | 11.36 | 5.96 |
| Return On Assets (%) | 7.92 | 5.17 | 1.34 |
| Total Debt / Equity (X) | 0.36 | 0.90 | 0.90 |
| Asset Turnover Ratio (%) | 0.75 | 0.77 | 0.64 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 26.17 |
| PBIT Margin (%) | 18.49 |
| PBT Margin (%) | 18.23 |
| Net PROFIT Margin (%) | 10.56 |
| Return On Networth / Equity (%) | 10.92 |
| Return On Networth /Employed (%) | 13.87 |
| Return On Assets (%) | 7.92 |
| Total Debt / Equity (X) | 0.36 |
| Asset Turnover Ratio (%) | 0.75 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 1,377.51 | 1,073.75 | 922.59 |
| Total Current Assets Annual | 1,494.54 | 951.17 | 951.93 |
| Non Current Assets Annual | 1,642.12 | 1,288.75 | 1,178.69 |
| Total Shareholders Funds Annual | 2,167.46 | 1,011.20 | 912.73 |
| Total Assets Annual | 3,136.66 | 2,239.92 | 2,130.62 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 1,377.51 |
| Total Current Assets Annual | 1,494.54 |
| Non Current Assets Annual | 1,642.12 |
| Total Shareholders Funds Annual | 2,167.46 |
| Total Assets Annual | 3,136.66 |
EPS (INR)
Expected
2.90
Reported
2.90
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 11.58%
